HC asks Centre if financial aid for rare diseases covers clinical trials of experimental DMD drug Read more
Pfizer to acquire Global Blood Therapeutics for $5.4 billion to enhance presence in rare haematology Read more
AstraZeneca’s Savannah phase-II trial shows 49 per cent objective response in lung cancer patients Read more